SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

MEDICINOVA INC
Date: Sept. 26, 2025 · CIK: 0001226616 · Accession: 0001193125-25-220448

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289801

Date
September 26, 2025
Author
/s/ Yuichi Iwaki
Form
CORRESP
Company
MEDICINOVA INC

Letter

Re: Acceleration Request of MediciNova, Inc. Registration Statement on Form S-1 Filed August 22, 2025 (File No. 333-289801) Ladies and Gentlemen: Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Tuesday, September 30, 2025, or as soon thereafter as practicable. The Registrant hereby authorizes Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration. Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060.

September 26, 2025 VIA EDGAR Division of Corporation Finance Office of Life Science United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Alan Campbell

Very truly yours,
/s/ Yuichi Iwaki

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 September 26, 2025
 VIA EDGAR Division of Corporation Finance
 Office of Life Science United States Securities and Exchange
Commission 100 F Street, N.E. Washington, D.C. 20549
 Attention:   Alan Campbell

 Re:
 Acceleration Request of MediciNova, Inc.
 Registration Statement on Form S-1
 Filed August 22, 2025
 (File No. 333-289801)
 Ladies and Gentlemen: Pursuant to Rules 460 and
461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “ Registrant ”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement,
to 4:00 p.m., Eastern Time, on Tuesday, September 30, 2025, or as soon thereafter as practicable. The Registrant hereby
authorizes Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, to orally modify or withdraw this request for acceleration.
 Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve
Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8060.

 Very truly yours,

 /s/ Yuichi Iwaki

 Yuichi Iwaki

 President and Chief Executive Officer